Spot Biosystems Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
2ndary - Private
- Investors
-
7
Spot Biosystems General Information
Description
Developer of a biotechnology platform designed to provide non-viral delivery of genetic medicines. The company utilizes extracellular vesicles to deliver genetic cargo, enables serial dosing, and targets skeletal muscle, enabling pharmaceutical companies to administer large genetic sequences without using viral vectors.
Contact Information
Website
www.spotbiosystems.comCorporate Office
- San Francisco, CA
- United States
Corporate Office
- San Francisco, CA
- United States
Spot Biosystems Timeline
Spot Biosystems Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Secondary Transaction - Private | 01-Jul-2026 | Completed | Clinical Trials - General | |||
| 4. Later Stage VC (Series A) | 17-Jun-2026 | Completed | Clinical Trials - General | |||
| 3. Early Stage VC | 01-Dec-2021 | Completed | Clinical Trials - General | |||
| 2. Accelerator/Incubator | 18-Mar-2020 | Completed | Clinical Trials - General | |||
| 1. Seed Round | 01-Jun-2018 | Completed | Clinical Trials - General |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Spot Biosystems Patents
Spot Biosystems Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026170082-A2 | Therapeutic tissue-targeting extracellular vesicles loaded with biomolecules | Pending | 07-Feb-2025 | ||
| WO-2026170082-A3 | Therapeutic tissue-targeting extracellular vesicles loaded with biomolecules | Pending | 07-Feb-2025 | ||
| EP-4795144-A2 | Multi-well electroporation devices and methods | Pending | 17-Oct-2023 | ||
| WO-2025083467-A2 | Multi-well electroporation devices and methods | Inactive | 17-Oct-2023 | ||
| WO-2025083467-A3 | Multi-well electroporation devices and methods | Inactive | 17-Oct-2023 | B01D67/0034 |
Spot Biosystems Signals
Spot Biosystems Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Light Silver Capital | Venture Capital | Minority | ||
| Angel (individual) | Minority | |||
| LH Ventures (China) | PE/Buyout | Minority | ||
| Saltagen Ventures | Venture Capital | Minority | ||
| Shanda (Private Equity) | PE/Buyout | Minority |
Spot Biosystems FAQs
-
When was Spot Biosystems founded?
Spot Biosystems was founded in 2018.
-
Where is Spot Biosystems headquartered?
Spot Biosystems is headquartered in San Francisco, CA.
-
What is the size of Spot Biosystems?
Spot Biosystems has 3 total employees.
-
What industry is Spot Biosystems in?
Spot Biosystems’s primary industry is Biotechnology.
-
Is Spot Biosystems a private or public company?
Spot Biosystems is a Private company.
-
What is Spot Biosystems’s current revenue?
The current revenue for Spot Biosystems is .
-
How much funding has Spot Biosystems raised over time?
Spot Biosystems has raised $40M.
-
Who are Spot Biosystems’s investors?
Light Silver Capital, , LH Ventures (China), Saltagen Ventures, and Shanda (Private Equity) are 5 of 7 investors who have invested in Spot Biosystems.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process